glp-1 agonist side effects Agonists The GLP-1 Agonists and Obesity:

The median (IQR) number of patients across studies was 355 (1295)

Please talk with your doctor about the risks and side effects before starting any GLP-1 medication

Long-Term Considerations: Published research indicates that weight management benefits of GLP-1 medications typically require ongoing treatment

There is a significant gap in research concerning the use of GLP-1 agonists during pregnancy, due to of lack of human studies as well as lack of data on their effects on lactation and fetal outcomes

Since absorption of fat-soluble vitamins and other lipid-dependent nutrients depends on bile acidmediated mechanisms, chronic therapy may reduce effective substrate delivery even when dietary composition appears adequate